Trial · NCT03505021
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Supine Slow Vital Capacity (SVC) | Levosimendan | -6.731 | 95% Confidence Interval -8.290 to -5.171 | percentage | |
| Supine Slow Vital Capacity (SVC) | Placebo for Levosimendan | -6.988 | 95% Confidence Interval -9.052 to -4.925 | percentage | |
| Combined Assessment of Function and Survival Through 48 Weeks | Levosimendan | 239.85 | Standard Error 10.98 | Scores on a rank scale | |
| Combined Assessment of Function and Survival Through 48 Weeks | Placebo for Levosimendan | 229.16 | Standard Error 13.31 | Scores on a rank scale | |
| Time to Respiratory Event Through 48 Weeks | Levosimendan | 90 | 95% Confidence Interval 82 to 144 | Days | |
| Time to Respiratory Event Through 48 Weeks | Placebo for Levosimendan | 126 | 95% Confidence Interval 82 to 169 | Days | |
| Change From the Baseline in Clinical Global Impression CGI at 48 Weeks | Levosimendan | 17.048 | 95% Confidence Interval 14.111 to 19.984 | units on a scale | |
| Change From the Baseline in Clinical Global Impression CGI at 48 Weeks | Placebo for Levosimendan | 13.285 | 95% Confidence Interval 9.252 to 17.318 | units on a scale | |
| Change From Baseline in Respiratory Function of ALSFRS-R at 48 Weeks | Levosimendan | -0.191 | Standard Error 0.015 | Score on a scale/month | |
| Change From Baseline in Respiratory Function of ALSFRS-R at 48 Weeks | Placebo for Levosimendan | -0.205 | Standard Error 0.022 | Score on a scale/month | |
| Supine Borg Category Ratio 10 Scale at 12 Weeks | Levosimendan | -0.152 | Standard Error 0.138 | score on a scale | |
| Supine Borg Category Ratio 10 Scale at 12 Weeks | Placebo for Levosimendan | 0.120 | Standard Error 0.186 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03505021/results